Generex Biotechnology Corporation

GNBT · OTC
Analyze with AI
4/30/2021
1/31/2021
10/31/2020
7/31/2020
Assets
Cash & Equivalents$1,675$596$834$15
Short-Term Investments$0$0$0$0
Receivables$52$169$184$165
Inventory$232$618$719$742
Other Curr. Assets$509$389$307$332
Total Curr. Assets$2,469$1,773$2,043$1,255
Property Plant & Equip (Net)$273$324$198$252
Goodwill$34,489$34,489$34,489$34,489
Intangibles$8,673$8,903$9,134$9,366
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$19$21$21$21
Total NC Assets$43,454$43,737$43,842$44,128
Other Assets$0$0$0$0
Total Assets$45,923$45,510$45,885$45,383
Liabilities
Payables$40,961$39,317$33,464$23,908
Short-Term Debt$8,634$10,150$10,010$10,735
Tax Payable$0$0$0$0
Deferred Revenue$7,000$3,000$0$0
Other Curr. Liab.$7,479$7,218$8,968$6,729
Total Curr. Liab.$64,074$59,685$52,443$41,371
LT Debt$654$615$500$500
Deferred Rev, NC-$1,502-$1,502-$1,502-$1,502
Deferred Tax Liab, NC$1,502$1,502$1,502$1,502
Other NC Liab.$29,352$44,396$29,050$15,470
Total NC Liab.$30,006$45,011$29,550$15,970
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$94,081$104,696$81,992$57,341
Equity
Pref Stock$0$0$0$0
Common Stock$116$113$108$82
Retained Earnings-$479,502-$488,724-$464,644-$452,063
AOCI$754$766$778$780
Other Equity$422,298$419,746$418,411$429,744
Total Equity-$56,333-$68,100-$45,346-$21,456
Supplemental Information
Minority Interest$4,074$4,074$4,074$0
Total Liab. & Tot. Equity$37,747$36,597$36,646$35,885
Net Debt$7,613$10,170$9,677$11,219